Energy & environment · 17/05/2007Updated: 10/17/2026 · 1 min read
GlaxoSmithKline Announces Availability of Environmental Assessment for Unrestricted Release of Building 7 at Hamilton Facility
Summary
GlaxoSmithKline has made available an environmental assessment and finding of no significant impact for a license amendment allowing unrestricted release of Building 7 at its Hamilton, Montana facility, previously licensed under Byproduct Materials License No. 25-19852-01.